Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Dawson James Downgrades BioCardia to Neutral

Dawson James Downgrades BioCardia to Neutral

Dawson James analyst Jason Kolbert downgrades BioCardia (NASDAQ:BCDA) from Buy to Neutral.

byBenzinga Newsdesk

November 11, 2022

1 minute read

Dawson James analyst Jason Kolbert downgrades BioCardia (NASDAQ:BCDA) from Buy to Neutral.

Pro-Bitcoin Ted Cruz Wants Capitol Vending Machines To Accept Crypto

By Mehab Qureshi

January 26, 11:04 PM

Senator Ted Cruz (R-Texas.) is proposing a new concurrent resolution that could see crypto accepted as a legitimate form of payment for vendors at the Capitol Hill complex.

BTC

Wells Fargo Maintains Overweight on Capital One Financial, Lowers Price Target to $130

By Benzinga Newsdesk

July 13, 7:21 AM

Wells Fargo analyst Donald Fandetti maintains Capital One Financial (NYSE:COF) with a Overweight and lowers the price target from $160 to $130.

COF

These Analysts Revise Their Forecasts On Oxford Industries Following Q4 Results

By Avi Kapoor

April 1, 2:51 PM

Oxford Industries, Inc. (NYSE: OXM) reported downbeat financial results for its fourth quarter and issued weak guidance for the first quarter on Thursday.

OXM

Morgan Stanley Maintains Equal-Weight on Rapid7, Lowers Price Target to $44

By Benzinga Newsdesk

December 19, 9:45 AM

Morgan Stanley analyst Hamza Fodderwala maintains Rapid7 (NASDAQ:RPD) with a Equal-Weight and lowers the price target from $55 to $44.

RPD

Dawson James Downgrades BioCardia to Neutral

Related Posts

Pro-Bitcoin Ted Cruz Wants Capitol Vending Machines To Accept Crypto

Wells Fargo Maintains Overweight on Capital One Financial, Lowers Price Target to $130

These Analysts Revise Their Forecasts On Oxford Industries Following Q4 Results

Morgan Stanley Maintains Equal-Weight on Rapid7, Lowers Price Target to $44